What are the harmful side effects using l carnitine
Reading File
Searching the Web
L-carnitine side effects harmful effects supplementation 2025
Searching PubMed
L-carnitine adverse effects supplementation
Finding Sources
Reading Web Page
https://www.explorationpub.com/Journals/ec/Article/101250
Reading File
I now have comprehensive information to give a detailed, well-sourced answer. Here is the full breakdown:
Harmful Side Effects of L-Carnitine
L-carnitine is generally well-tolerated at dietary intake levels, but supplementation - especially at doses above 2 g/day - carries a range of side effects, from mild GI issues to serious long-term cardiovascular risks.
1. Gastrointestinal Side Effects (Most Common)
These are the most frequently reported effects and are dose-dependent:
- Nausea and vomiting
- Stomach cramps and abdominal pain
- Diarrhea
- Heartburn / dyspepsia
- Upset stomach
These typically occur at doses of 3 g/day or higher. Most GI side effects resolve when the dose is reduced.
2. Fishy Body Odor (Trimethylaminuria)
L-carnitine is metabolized by gut bacteria into trimethylamine (TMA), which is oxidized to TMAO and excreted through sweat, urine, and breath. This produces a characteristic fishy body odor - a well-documented side effect even at moderate doses. - Kaplan & Sadock's Synopsis of Psychiatry
3. TMAO and Cardiovascular Risk (Most Serious Long-Term Concern)
This is the most significant harmful effect identified by recent research.
When you take oral L-carnitine, gut bacteria convert it into trimethylamine-N-oxide (TMAO). Elevated TMAO levels are directly linked to:
- Atherosclerosis (plaque buildup in arteries)
- Increased risk of heart attack (myocardial infarction)
- Stroke
- Atrial fibrillation (AF)
- Heart failure (HF)
- Higher all-cause mortality - each 10 µmol/L increment in TMAO raises all-cause mortality by 7.6%
A 2025 review in Exploration Cardiology specifically warns that long-term L-carnitine supplementation should be strictly avoided, particularly for individuals with pre-existing cardiovascular or renal conditions. Short-term use showed benefits, but prolonged use elevates fasting TMAO plasma levels up to ten-fold compared to controls after just 3 months.
The 2020 systematic review by Sawicka et al. (PMC7507632) confirms these concerns but notes the relationship between TMAO and disease may also partly reflect underlying kidney or metabolic dysfunction.
4. Neurological Side Effects
- Seizures - reported with acetyl-L-carnitine (the brain-penetrant form); particularly concerning in people with seizure disorders
- Increased agitation - documented in some Alzheimer's disease patients
- Restlessness - at high doses
Source: Kaplan & Sadock's Synopsis of Psychiatry, Table 21-62
5. Kidney-Related Concerns
- People with chronic kidney disease (CKD) have impaired TMAO excretion, causing dangerous accumulation in plasma
- L-carnitine supplementation can worsen TMAO buildup in this population
- High plasma TMAO is a recognized marker of kidney damage
6. Drug Interactions
Acetyl-L-carnitine (a related form) can interact with:
- Valproic acid (may alter serum levels)
- Nucleoside analog antivirals (e.g., AZT) - may deplete carnitine or cause interactions
- Pivaloyl-containing antibiotics (can deplete carnitine stores)
Source: Kaplan & Sadock's Synopsis of Psychiatry
7. Gut Microbiome Disruption
Chronic L-carnitine intake has been shown to alter the Firmicutes-to-Bacteroidetes (F/B) ratio in the gut, favoring populations that produce more TMAO - a form of gut dysbiosis that may persist even after stopping supplementation.
Summary Table
| Side Effect | Severity | Notes |
|---|---|---|
| GI distress (nausea, diarrhea, cramps) | Mild-Moderate | Dose-dependent, common above 3 g/day |
| Fishy body odor | Mild | Due to TMA production by gut bacteria |
| Elevated TMAO / Cardiovascular risk | Serious | Atherosclerosis, MI, stroke, AF, HF |
| Seizures | Serious | Mainly with acetyl-L-carnitine form |
| Agitation in Alzheimer's patients | Moderate | With acetyl-L-carnitine specifically |
| Worsening CKD / renal TMAO burden | Serious | Dangerous in pre-existing kidney disease |
| Gut dysbiosis | Moderate-Serious | Long-term microbial shift |
Safe dose: Up to 2 g/day is generally considered safe for chronic supplementation. Doses of 6 g/day for up to 12 months have been used in clinical trials without major direct toxic events, but the long-term TMAO concern remains regardless of dose.
Bottom line: For healthy individuals, short-term L-carnitine supplementation is mostly safe with minor GI side effects. The most clinically important risk is the TMAO-mediated cardiovascular harm with long-term use - a risk that is often overlooked in marketing of this supplement.
This is a shared conversation. Sign in to Orris to start your own chat.